Cita APA

Rosman, Y., Lavi, N., Meir-Shafrir, K., Lachover-Roth, I., Cohen-Engler, A., Mekori, Y. A., & Confino-Cohen, R. (2021). Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders. J Allergy Clin Immunol Pract.

Chicago Style Citation

Rosman, Yossi, Noa Lavi, Keren Meir-Shafrir, Idit Lachover-Roth, Anat Cohen-Engler, Yoseph A. Mekori, i Ronit Confino-Cohen. "Safety of BNT162b2 MRNA COVID-19 Vaccine in Patients With Mast Cell Disorders." J Allergy Clin Immunol Pract 2021.

Cita MLA

Rosman, Yossi, et al. "Safety of BNT162b2 MRNA COVID-19 Vaccine in Patients With Mast Cell Disorders." J Allergy Clin Immunol Pract 2021.